Skip to main content
. Author manuscript; available in PMC: 2015 Jul 1.
Published in final edited form as: ChemMedChem. 2014 May 14;9(7):1602–1614. doi: 10.1002/cmdc.201300546

Table 6.

Plasma pharmacokinetic parameters of compound 11h after a single intravenous (3.0 mg kg−1) or oral administration (10 mg kg−1) in rats

Parameters 3.0 mg kg−1 (IV)[a] 10mg kg−1 (PO)[a]
Cmax (ng mL−1) 397 570
Tmax (h) 0.08 0.25
AUC (ng h mL−1) 111 247
Cl (mL min−1 kg−1) 702
F (%) 67

Cmax = Maximum observed concentration; AUC = Cumulative area under curve for experimental time points (0–24 h); Cl = Systemic clearance based on observed data points (0–24 h); F = Bioavailability.

[a]

Compound was dosed in 10% PEG400/10% Tween 80/80% Saline solution; three animals per dose were treated.